Myeloid Malignancy Flashcards

1
Q

In which cells of the bone marrow do myeloid malignancies arise? (4)

A
  • Erythrocytes
  • Megakaryocyte = platelets
  • Granulocytes = neutrophils, eosinophils and basophils
  • Monocytes = macrophages + dendritic cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

In which cells produced by the bone marrow do lymphoid malignancies arise? (2)

A
  • B-cells
  • T-cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where do almost all the myeloid malignancies originate from?

A
  • The haematopoietic stem cells or the early myeloid progenitor cells
  • Different mutations within the H stem cell lead to different phenotypes of disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the main groups of myeloid malignancy? (4)

A
  • Acute myeloid leukaemia (AML)
  • Chronic myeloid leukaemia (CML)
  • Myelodysplastic Syndromes (MDS) - pre-leukaemic conditions
  • Myeloproliferative neoplasma (MPN)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the key difference between the development of Acute Myeloid/myeloblastic Leukaemia and Myeloproliferative disorders such as Chronic Myeloid Leukaemia?

A

Acute myeloid leukaemia = proliferation without any differentiation

Myeloproliferative disorders e.g CML, polycythemia vera etc – proliferation AND differentiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Characteristics of Acute Myeloid Leukaemia

A
  • Leukaemic cells do not differentiate - they proliferate and are resistant to dying but they do not mature/differentiate
  • Bone marrow failure - bone marrow fills up with blast cells so the AML replaces the bone marrow and then it fails
  • Rapidly fatal if untreated
  • Potentially curable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Characteristics of Chronic Myeloid Leukaemia

A
  • Leukaemic cells retain ability to differentiate
  • Proliferation without bone marrow failure
  • Long term survival/possible cures with modern therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are 2 important subgroups of Acute Leukaemia?

A
  • Acute Myeloblastic Leukaemia (AML)
  • Acute Lymphoblastic Leukaemia (ALL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the key clinical features of Acute myeloid/myeloblastic leukaemia? (3)

A

Bone marrow failure (Triad) - failure of the 3 lineages (erythrocytes, platelets and granulocytes/monocytes) and as a result you get:

  • Anaemia
  • Thrombocytopenic bleeding (platelet pattern - purpura, mucosal membrane bleeding etc)
  • Infection because of neutropenia (predominantly bacterial and fungal) - lungs (fungal pneumonia), brain abscess etc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Look

A
  • Fungal/bacterial infection is so serious in patients with AML and it is because of this infection risk that you cannot bring flowers or have standing water on these wards.
  • Building work also releases spores of aspergillus which can cause death of these patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the essential investigations done for AML?

A
  • Blood count and blood film - thrombocytopenia, neutropenia, leukaemic cells in blood (may not have all of these)
  • Bone marrow aspirate (fluid) or trephine biopsy (tissue)
    • Diagnose it when blast cells > 20% of marrow cells in acute leukaemia
    • ​Cytogenetics (Karyotype) from leukaemic blasts - more specific diagnosis - done to find out about growth abnormalities (acquired) in the chromosomes
    • Immunophenotyping of leukaemic blasts - identifies whether it is myeloid and lymphoid
  • Lumbar puncture - CSF examination if suspected CNS involvement- more common in children

Future = genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is Acute Myeloid Leukaemia treated?

A
  • Supportive care = vital - high quality care with specialised units. Important as you have to get the patient through 5 weeks of absolute bone marrow failure if you use intense therapy
  • Anti-leukaemic chemotherapy - 3 parts to it
    • Remission induction - to achieve remission = normal blood counts and less than 5% blasts - daunorubicin
    • Consolidation of remission - high dose cytosine arabinoside or some recieve allogenic stem cell transplantation (most successful treatment but complex)
    • Maintenance - Midostaurin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical features of Chronic Myeloid Leukaemia

A
  • Anaemia - not due to bone marrow failure as such but more due to chronic disease
  • Splenomegaly - often massive due to proliferation within the spleen
  • Weight loss - hypercatabolic state
  • Hyperleukostasis - high WCC
    • Can cause fundal haemorrhage and venous congestion
    • A very high WCC leads to altered consciousness and respiratory failure
  • Gout - a lot of uric acid made due to proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Typical CML blood count

A
  • The WCC is very high but notice the different types of white cell count! There are a small number of blasts but lots of other white cells - as we know, the cells in CML differentiate and don’t form blast cells.
  • Slightly anaemic
  • High platelet count
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the name of the translocation mutation that is a hallmark of CML?

A

The philadelphia chromosome Translocation t(9;22)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is CML treated?

A
  • Tyrosine Kinase Inhibitors = 1st line - they inibit BCR-ABL (found in almost all CML patients)
    • Imatinib
    • Dasatinib
    • Nioltinib
    • Busitinib
    • Ponatinib
  • Allogenic transplantation - only used if TKI drugs fail
17
Q

What are some myeloproliferative disorders other than CML?

A
  • Polycythaemia Vera
  • Essential thrombocythaemia
  • Idiopathic myelofibrosis - General feeling is that this is just a more advanced stage of PV and ET
18
Q

Which mutation is common in PV, ET and myelofibrosis?

A

JAK2 mutation

  • In 95% of PV
  • In 50% of ET and myelofibrosis
19
Q

What are the clinical features of PV? (6)

A
  • Headaches
  • Itch
  • Vascular occlusion
  • Thrombosis
  • TIA, stroke
  • Splenomegaly - proliferation
20
Q

What is a typical blood count in PV?

A
  • Dramatic raise in Hb
  • Haematocrit is high
  • Platelets are high – stem cell disorder
  • Raised uric acid + risk of gout
  • A true increase in red cell mass when the blood volume is measured - proliferation
21
Q

How is PV treated?

A

KEY THING in treatment of PV is to reduce vascular risk!! Quite like treating hypertension.

  • Venesection - take blood away to keep haematocrit below 0.45 in men and 0.43 in women
  • Aspirin - reduce risk of thrombosis
  • Cytoreduction with chemotherapy like drug - reduce/supress WBC count or platelet levels
22
Q

What is the natural history of PV like?

A
  • Stroke and other arterial or venous thromboses if poorly controlled
  • Bone marrow failure from the development of secondary myelofibrosis
  • Transformation to AML
23
Q

Essential thrombocythaemia - discuss

A

Myeloproliferative disease with predominant feature of raised platelet count

  • 50% positive for JAK2V617F mutation
  • 20% CARL mutation
  • Symptoms of arterial and venous thromboses, digital ischaemia, gout or headache
  • Mild splenomegaly
  • Can progress to myelofibrosis or AML
24
Q

What is Polycythaemia vera and essential thrombocythaemia?

A

Polycythaemia vera = proliferation of eryhtroid cell line

Essential thrombocythaemia = proliferation of megakaryocytic cell line (cells that become platelets)